Ivan Kairatov is a leading biopharma expert with a distinguished background in structural biology and drug development, currently focusing on the mechanics of cellular signaling. His work bridges the gap between high-resolution molecular imaging and the practical application of these insights to
The modern biomanufacturing landscape faces a persistent bottleneck where the transition from laboratory discovery to commercial-scale production often results in significant performance losses. Traditional screening methods frequently rely on microfluidic droplets or well plates that do not
Nature has perfected the art of molecular architecture over billions of years, creating viral capsids that serve as the gold standard for structural efficiency and protective capability. These biological shells are composed of hundreds or even thousands of identical protein subunits that
The ability to observe the most intricate biological processes within a living organism represents one of the final frontiers of modern medicine, and today, the Department of Bioengineering at Imperial College London is leading this charge with a series of well-funded initiatives. Recent support
Ivan Kairatov is a distinguished expert in the biopharmaceutical sector, recognized for his deep specialization in research and development and the integration of innovative technologies in cancer care. His work frequently bridges the gap between complex bioengineering and clinical application,
The rapid maturation of genetic engineering has catalyzed a fundamental shift in how the pharmaceutical industry conceptualizes the stimulation of the human immune system during vaccination. While traditional vaccines primarily focused on the induction of neutralizing antibodies to intercept
